Get in touch with NEXO Beauty Labs Company

Contact Form 使用中
OPTIONAL DETAILS Company Information

Private Label Moisturizers

Private Label Moisturizers and Ceramide Face Cream Manufacturing

NEXO Beauty Labs develops private label moisturizers for beauty brands that need a clear development route, a defined texture, and packaging decisions that can move into commercial production. Start with a mature base, adapt an existing direction, or build a custom formulation around the way your skin care product should feel, dispense, and fit your range.

  • 3 business days for formula/texture samples
  • 5–7 business days for international sample delivery
  • 10,000-unit MOQ
  • Jar, tube, or airless pump directions

A useful first conversation is concrete

Bring your target market, texture reference, preferred pack, ingredient direction, claims plan, and expected order quantity. We use those inputs to define the development route before the formula, label, and packaging work drift into separate projects.

Your enquiry can start with a formula concept, a texture benchmark, or a product gap in your skincare line.

Private Label Moisturizers and Ceramide Face Cream Manufacturing
3 routes
Mature formula, formula adaptation, or custom development
10,000 units
Confirmed minimum order quantity
25+ years
Cosmetic manufacturing expertise built from a 1999 foundation
3 business days
Formula and texture sample development
5–7 business days
International sample delivery after dispatch
Within 15 days
Commercial production after packaging arrives and passes inspection

Manufacturing foundation

NEXO Beauty Labs is a cosmetic OEM and ODM partner for skincare, hair care, and body care. Our capabilities include skincare product development, formulation innovation, scalable manufacturing, production management, and quality control. Our manufacturing foundation dates back to 1999, giving the team more than 25 years of cosmetic manufacturing expertise.

Development

Moisturizer Development Routes

NEXO combines product development, formulation work, production management, and quality control in one manufacturing program. As a private label skincare manufacturer, our role is to help turn a defined brief into products for the market while keeping route, pack, testing, and approval decisions visible. Your chosen route controls how much is already decided, how much needs to be tested, and how many brand-specific choices remain open. Published prototype evidence shows why those test and approval gates matter even when products begin from the same development program.

Mature formula

Choose an available moisturizer direction when speed and a proven development starting point matter more than a proprietary formula architecture. Branding, packaging, fragrance direction, and product positioning still need a written brief.

  • Best for a faster private label launch
  • Useful when the desired texture is already clear
  • Keeps the decision set smaller

Formula adaptation

Start from an existing formulation and adjust selected sensory or brand elements. This route fits a beauty brand that wants more distinction without reopening every raw-material and emulsion decision.

  • Texture, fragrance, and selected active directions
  • Pack and dispensing review
  • Defined comparison against the approved sample

Custom development

Build the cream around a new brief when the target texture, ingredient system, positioning, or packaging interaction cannot be reached through a light change. Custom development needs the clearest market and claims inputs because each extra objective changes the formulation problem.

  • New formula architecture
  • Brand-specific sensory target
  • Planned validation and revision checkpoints

Route decision

A private label and custom program should not be chosen from a slogan. Choose the least complex route that can still deliver the product distinction your brand needs, then protect that decision with an approved sample and an exact manufacturing brief.

Route mismatch becomes a real risk because a 10,000-unit commitment magnifies a poor development choice. NEXO Beauty Labs resolves that risk by defining what is fixed, what can be adapted, and what must be developed and validated before commercial production.

Commercial comparison

A skincare brand comparing private label skincare routes may see RainShadow Labs and other established names across the beauty industry. NEXO’s private label skin care offer ties the private label cosmetic brief to confirmed MOQ and milestone conditions, because high-quality beauty products and care products need more than generic promises.

What procurement teams should challenge

Buyers worry that slow or vague communication will surface after packaging, deposits, or launch dates are committed. MOQ is not useful by itself: a private label skincare low MOQ search can hide formula-route, pack, testing, and inventory assumptions. Formula revisions, texture changes, and pack changes can become the real critical path even when a production window looks fast.

For buyers comparing wholesale skincare private label programs or a skincare manufacturer China search result, the common assumption that the smallest quantity is the safest commitment is not always true. Cheapest is not always best when the pack cannot dispense the approved texture. This is the trade-off, and the catch is that formula, pack, claims, and destination-market duties are not interchangeable. Locking any one of them before the others are visible is the wrong call.

Ingredient presence is a formulation direction, not finished-product proof. Match claims to the approved formula and the evidence available for the intended market.

Hydration, Barrier and Active-Ingredient Directions

A moisturizer is a finished system, not a stack of fashionable ingredients. Humectant, emollient, occlusive, antioxidant, botanical, lipid, and active-ingredient choices need to work with the emulsion, sensory target, skin types, pack, and intended claims. Formulation research also shows that prototype stability and sensory behavior need to be assessed on the finished composition rather than inferred from an ingredient list.

Hydration system

Hyaluronic acid, glycerin, saccharide isomerate, panthenol, and polysaccharide directions can be discussed for hydration and moisture retention. A useful brief states whether the product should feel weightless, cushioned, rich, or suitable under makeup.

Best fit: a daily moisturizer, deep hydration concept, or a formula designed to hydrate without an overly heavy finish.

Ceramide and lipid system

Ceramide NP, AP, or EOP, cholesterol, phytosphingosine, and squalane may be explored as skin-identical lipid directions. A private label ceramide cream still needs an emulsion and validation plan; a multi-ceramide complex name alone does not prove barrier repair or reduced transepidermal water loss.

Best fit: a richer facial moisturizer concept intended to nourish dry or stressed skin and address dryness comfort. Finished-product evidence must support any moisture-loss or skin-barrier claim.

Comfort and botanical system

Panthenol, oat, aloe, Tremella, Dendrobium, ectoin, and other botanical directions can be reviewed for a calm, soothe, or comfort-led concept. Any sensitive skin, barrier-compromised, microbiome, postbiotic, skin flora, or innate immune system language needs market-specific review and finished-product support.

Best fit: a formula story built around comfort and resilience rather than an aggressive anti-aging promise.

Active skincare system

Peptide, vitamin C, retinol-support, niacinamide, antioxidant, avocado oil, shea butter, or other active directions can be scoped by compatibility and positioning. Final INCI, concentration, stability, and claims should follow the approved formulation rather than a wish list.

Best fit: a moisturizer that complements an active serum, sunscreen, or treatment step without turning this page into a separate hair care, body care, eye shadow, lipstick, or lip gloss offer.

Ceramide brief checkpoint

For a private label ceramide cream, specify the texture, day or night use, target pack, preferred ceramide direction, supporting lipids, and the wording you plan to place on the label. NEXO can formulate against that brief; the finished formula and its substantiation determine which claims can move forward.

Texture and Packaging Directions

One moisturizing concept can feel completely different as a lightweight emulsion, rich cream, overnight cream, or water-in-oil system. Packaging belongs in that decision because viscosity, air exposure, dispensing, decoration, and everyday use all meet at the pack. Published sensory testing found meaningful differences in spread, absorption, stickiness, greasiness, and smoothness among prototypes.

Private Label Moisturizers Texture and Packaging
Direction What it helps define Packaging questions
Lightweight daily cream Fast spread, lower residue, easy layering with other skincare products Tube or airless pump; dose, closure, and label area
Rich barrier cream Cushion, nourishment, squalane or ceramide direction, overnight comfort Jar, tube, or airless format; fill behavior and user access
Overnight cream Longer wear, smooth finish, richer sensory profile Jar or controlled-dose pack; decoration and secondary packaging
Water-in-oil cream More occlusive sensory direction and moisture-retention positioning Pump compatibility, filling behavior, and pack interaction

Pack formats to brief

  • Jar for direct access and richer textures
  • Tube for portable, familiar dispensing
  • Airless pump for controlled dispensing and reduced repeated exposure

Claims and finish choices

  • Fragrance direction or fragrance-free target
  • Silicone-free, vegan, or clean beauty requests as options requiring formula and market confirmation
  • Artwork, label, carton, and decoration scope

Project Specifications for Moisturizer Programs

These are the confirmed planning facts for the current NEXO moisturizer offer. Formula-specific performance, final ingredient composition, packaging compatibility, and target-market files are decided inside the project rather than implied by this table. U.S. and EU market-readiness responsibilities include safety and product-information work that must be assigned to the appropriate market role.

Project Item Confirmed Working Point Buyer Input
Development routes 3 routes Mature formula, adaptation, or custom formulation
Formula / texture sample development 3 business days Accepted brief and reference direction
International sample delivery 5–7 business days Destination and shipping details
Commercial production Within 15 days Packaging must have arrived and passed inspection
Minimum order 10,000 units SKU, size, pack, decoration, and shipping plan
Packaging directions 3 core formats Jar, tube, or airless pump
Texture directions 4 starting formats Lightweight, rich, overnight, or water-in-oil
Current ingredient discussion set 6 named directions Hyaluronic acid, ceramide, panthenol, peptide, ectoin, or squalane
Project Specifications for Moisturizer Programs

MOQ, Cost Drivers and Lead-Time Milestones

Pricing reflects the development route, formula scope, raw-material choices, product size, packaging, decoration, testing plan, order quantity, and logistics. Send a complete brief for a written quotation; a unit-price shortcut without those inputs would hide the variables that matter.

Cost drivers that deserve an early decision

Driver
Why it changes the project
Useful buyer action
Formula route
Custom development opens more formulation, sample, and revision work than a mature formula.
Choose the least complex route that still protects differentiation.
Active ingredients
Availability, compatibility, concentration, and claim intent affect formulation and sourcing.
Separate required active ingredients from optional ideas.
Texture and pack
Viscosity, dispensing, fill method, decoration, and component sourcing are linked.
Bring a pack preference before the sample is approved.
Testing and market files
Safety, stability, compatibility, claims, label, and notification needs depend on product and market scope.
Name the first launch market and intended claims.
MOQ and sell-through
10,000 units create inventory, freight, storage, and cash exposure.
Run a slower sales scenario as well as the target forecast.

Three clocks, three owners

Sample development

We develop the formula and texture sample in 3 business days after the brief is accepted. Revisions begin a new decision cycle and should be recorded against the last approved sample.

Sample delivery

International sample delivery is 5–7 business days. Destination details and dispatch confirmation belong in the project schedule rather than being folded into the development time.

Commercial production

We complete commercial production within 15 days after packaging arrives and passes inspection. Packaging manufacture, transit to the factory, inspection, and any correction sit before that window.

Inventory check before order release

Our minimum order is 10,000 units. Match it to conservative sell-through, storage, batch coding, market-specific labels, launch channels, and reorder timing before you treat a low unit cost as a low-risk decision.

Formula, Sample and Packaging Validation

Formula intent is only the starting point. A peer-reviewed 2025 topical-formulation study found that three of four prototypes remained physically stable while one phase-separated; the formulas also differed in spreading, absorption, stickiness, greasiness, and smoothness.

What that means for a private label face cream manufacturer brief

  • Validate the actual formula, sensory target, dispensing format, and pack combination planned for sale. That study is not evidence for a NEXO product result; it is a practical reason to keep development gates visible.
  • Freeze the brief. Record the route, target market, texture, packaging direction, ingredient priorities, and claims intent.
  • Review the formula and texture sample. Compare spread, absorption, residue, fragrance, appearance, and after-feel against one written reference.
  • Confirm the pack direction. Align viscosity, fill, dispensing, closure, user handling, label area, and decoration before component quantities are locked.
  • Define formula-specific checks. Agree on the stability, compatibility, safety, microbiology, quality-control, or third-party efficacy work required for the product and market.
  • Approve the commercial standard. Tie production to the approved sample, packaging specification, artwork, quantity, and acceptance criteria.

We support formula optimization, ingredient selection, sample development, production management, quality control, and third-party efficacy-testing coordination where it is part of the approved scope. Brand teams and their market advisers still need to decide which claims and market obligations apply to the finished cosmetic.

Enlarged Moisturizer Sample

Moisturizer Concepts for Different Brand Positions

NEXO’s current development material covers daily, rich, overnight, dry-skin comfort, sensitive-skin direction, and post-retinol comfort concepts. Each one is a starting position to formulate and test, not a fixed claim set or a promise that every active appears in one formula.

Treating these names as finished specifications is a mistake. NEXO turns the chosen position into a sample brief because texture, active load, package dispensing, and claim scope need to be reviewed as one product system; prototype stability and sensory results cannot be assumed from the concept name.

Daily Hydration Cream

A lightweight moisturizer direction for easy spread and routine layering. Hyaluronic acid, glycerin, panthenol, or botanical components may support the formula story after compatibility review.

Rich Ceramide Cream

A richer private label ceramide direction using selected lipid, ceramide NP, cholesterol, phytosphingosine, or squalane ideas. Claim language and formula details should follow the approved composition.

Overnight Comfort Cream

A more cushioned sensory target for night use or dry-feel positioning. Packaging, fragrance direction, active load, and residue preference should be briefed together.

Jar Direction Tube Direction Airless Direction

Cases That Need a Different Starting Point

Private label moisturizers fit projects with a clear cosmetic use, a realistic 10,000-unit volume, and enough room to align the formula, pack, label, and market scope. Some briefs need a different route before sample work begins, especially when intended use or market responsibility changes the evidence and notification path.

Cases That Need a Different Starting Point
Situation Why it works against the project Better next step
A brief depends on a drug or disease-treatment claim Intended use may change the regulatory path and required evidence. Resolve classification and claims strategy with qualified market counsel before formula release.
An order cannot support 10,000 units Confirmed MOQ creates excess inventory and cash exposure. Validate sell-through, reduce SKU count, or choose a route designed for a smaller launch.
A brand wants every active in one cream Compatibility, texture, stability, cost, and claim objectives can conflict. Rank must-have ingredients and move secondary ideas into a serum or future sibling product.
Packaging is not yet selected but artwork is being finalized Label area, fill, closure, and decoration limits may force late changes. Lock the pack direction before final artwork and commercial quantities.
A product must ship with an unverified certification or efficacy statement Identity and performance claims need exact scope and supporting records. Obtain the applicable evidence before the statement enters the label or sales copy.

Private Label Moisturizer Planning & Execution Tools

01
Tool 01

Private Label Moisturizer Formula Route Selector

Choose the route that matches how much is already defined. The result is a briefing aid, not a formulation or market-compliance approval.

Access Tool
02
Tool 02

MOQ Inventory Estimator

NEXO’s confirmed minimum order quantity is 10,000 units. Enter your own sell-through and landed-cost assumptions to see the inventory exposure; no price is prefilled.

Access Tool
03
Tool 03

Sample-to-Production Timeline Planner

Map the three confirmed milestones without merging them into one launch promise. Business-day dates exclude weekends; public holidays, revisions, testing, packaging supply and freight beyond sample delivery are not estimated.

Access Tool
04
Tool 04

Texture and Packaging Brief Builder

Turn product ideas into a cleaner first RFQ. The listed actives are formulation directions, not a promise that every ingredient will appear in one finished formula.

For a more detailed buyer checklist, read our moisturizer formulation and manufacturing guide.

Access Tool

FAQ for Moisturizer Buyers

A mature formula route keeps the decision set smallest, while formula adaptation and custom development open more variables. NEXO develops the initial formula and texture sample in 3 business days after the brief is accepted.
Yes. Ceramide NP, AP, EOP, cholesterol, phytosphingosine, squalane, and other lipid directions can be discussed, but the approved formula determines the final INCI and claim scope.
Texture and sensory adaptation can be part of the brief. Send the reference, then state what should stay and what should change across spread, absorption, residue, richness, fragrance, and finish.
Current project directions include jars, tubes, and airless pumps. Format choice depends on texture, dispensing, filling, exposure, decoration, target size, and consumer use.
Our confirmed MOQ is 10,000 units. Use the MOQ Inventory Estimator to compare that quantity with your own sell-through and landed-cost assumptions.
Formula and texture sample development is 3 business days. International sample delivery is a separate 5–7-business-day milestone.
Commercial production is completed within 15 days after packaging arrives and passes inspection. Packaging manufacture, transport, inspection, revisions, testing, and commercial freight are separate project dates.
MoCRA assigns duties to the responsible person and includes facility-registration, product-listing, adverse-event, and safety-substantiation requirements.1 Define who owns each task for the finished cosmetic; manufacturing support should not be read as automatic transfer of every responsibility.
EU rules include a product safety report, an EU responsible person, and centralized CPNP notification before placement on the market.2 Set those owners before label and commercial production decisions are locked.
Those directions can be included in the formulation brief. Availability and public wording depend on the approved formula, raw-material documentation, manufacturing scope, target market, and the standard or retailer rule the brand plans to use.